• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人源 C5 单链可变片段改善 NMOSD 模型中的脑损伤。

Human C5-specific single-chain variable fragment ameliorates brain injury in a model of NMOSD.

机构信息

Key Laboratory of the Ministry of Education for Medicinal Resources and Natural Pharmaceutical Chemistry (W.Z., Z.W., S.H., Y.G., Y.L., H.S., X.D., Y.F., Y.Y.), National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest of China, College of Life Sciences, Shaanxi Normal University, Xi'an; Department of Neurology (W.Z.), Tianjin Neurological Institute, Tianjin Medical University General Hospital; and Department of Neurology (Z.W.), Xuanwu Hospital, Capital Medical University, Beijing, China.

出版信息

Neurol Neuroimmunol Neuroinflamm. 2019 Apr 4;6(3):e561. doi: 10.1212/NXI.0000000000000561. eCollection 2019 May.

DOI:10.1212/NXI.0000000000000561
PMID:31044149
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6467685/
Abstract

OBJECTIVE

Using phage display, we sought to screen single-chain variable fragments (scFvs) against complement C5 to treat neuromyelitis optica spectrum disorder (NMOSD).

METHODS

After 5 rounds of phage display, we isolated individual clones and identified phage clones specifically binding to C5 using ELISA. Using aquaporin-4 (AQP4)-transfected cells in vitro, we confirmed whether these scFvs prevented complement-dependent cytotoxicity (CDC) caused by the serum of patients with NMOSD and human complement (hC). We selected an NMOSD mouse model, in which intracerebral NMOSD immunoglobulin G (IgG) and hC injections induce NMOSD-like lesions in vivo.

RESULTS

We obtained scFvs to test specificity and blocking efficiency. The scFv C5B3 neutralized C5 in the complement activation pathway, which prevented AQP4-IgG-mediated CDC in AQP4-transfected cells. In an NMOSD mouse model, C5B3 prevented AQP4 and astrocyte loss, decreased demyelination, and reduced inflammatory infiltration and membrane attack complex formation in lesions.

CONCLUSIONS

We used phage display to screen C5B3 against C5, which was effective in inhibiting cytotoxicity in vitro and preventing CNS pathology in vivo.

摘要

目的

通过噬菌体展示技术,筛选针对补体 C5 的单链可变片段(scFv),以治疗视神经脊髓炎谱系疾病(NMOSD)。

方法

经过 5 轮噬菌体展示,我们分离了单个克隆,并通过 ELISA 鉴定出与 C5 特异性结合的噬菌体克隆。我们使用体外转染水通道蛋白-4(AQP4)的细胞,证实这些 scFv 是否能阻止 NMOSD 患者血清和人补体(hC)引起的补体依赖性细胞毒性(CDC)。我们选择了 NMOSD 小鼠模型,在该模型中,脑内 NMOSD IgG 和 hC 注射可在体内诱导 NMOSD 样病变。

结果

我们获得了 scFv 以测试其特异性和阻断效率。scFv C5B3 中和了补体激活途径中的 C5,阻止了 AQP4-IgG 介导的转染 AQP4 细胞中的 CDC。在 NMOSD 小鼠模型中,C5B3 可防止 AQP4 和星形胶质细胞丢失,减少脱髓鞘,减少病变中的炎症浸润和膜攻击复合物形成。

结论

我们使用噬菌体展示技术筛选出针对 C5 的 C5B3,该 scFv 可有效抑制体外细胞毒性,并预防体内中枢神经系统病理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3d3/6467685/f2faecf2222f/NEURIMMINFL2018018598f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3d3/6467685/35c692228b11/NEURIMMINFL2018018598f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3d3/6467685/2563222edaf2/NEURIMMINFL2018018598f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3d3/6467685/ce7853eb2305/NEURIMMINFL2018018598f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3d3/6467685/226527f24abf/NEURIMMINFL2018018598f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3d3/6467685/f2faecf2222f/NEURIMMINFL2018018598f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3d3/6467685/35c692228b11/NEURIMMINFL2018018598f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3d3/6467685/2563222edaf2/NEURIMMINFL2018018598f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3d3/6467685/ce7853eb2305/NEURIMMINFL2018018598f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3d3/6467685/226527f24abf/NEURIMMINFL2018018598f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3d3/6467685/f2faecf2222f/NEURIMMINFL2018018598f5.jpg

相似文献

1
Human C5-specific single-chain variable fragment ameliorates brain injury in a model of NMOSD.人源 C5 单链可变片段改善 NMOSD 模型中的脑损伤。
Neurol Neuroimmunol Neuroinflamm. 2019 Apr 4;6(3):e561. doi: 10.1212/NXI.0000000000000561. eCollection 2019 May.
2
Targeting the complement system in neuromyelitis optica spectrum disorder.靶向视神经脊髓炎谱系疾病中的补体系统。
Expert Opin Biol Ther. 2021 Aug;21(8):1073-1086. doi: 10.1080/14712598.2021.1884223. Epub 2021 Feb 16.
3
Memantine ameliorates motor impairments and pathologies in a mouse model of neuromyelitis optica spectrum disorders.美金刚改善视神经脊髓炎谱系障碍小鼠模型中的运动障碍和病理变化。
J Neuroinflammation. 2020 Aug 11;17(1):236. doi: 10.1186/s12974-020-01913-2.
4
Staging of astrocytopathy and complement activation in neuromyelitis optica spectrum disorders.视神经脊髓炎谱系疾病中天麻素病和补体激活的分期。
Brain. 2021 Sep 4;144(8):2401-2415. doi: 10.1093/brain/awab102.
5
Cytoprotective IgG antibodies in sera from a subset of patients with AQP4-IgG seropositive neuromyelitis optica spectrum disorder.AQP4-IgG 血清阳性视神经脊髓炎谱系疾病患者亚组血清中的细胞保护 IgG 抗体。
Sci Rep. 2021 Nov 9;11(1):21962. doi: 10.1038/s41598-021-01294-3.
6
Regulatory T cells protect against brain damage by alleviating inflammatory response in neuromyelitis optica spectrum disorder.调节性 T 细胞通过减轻视神经脊髓炎谱系疾病中的炎症反应来保护大脑免受损伤。
J Neuroinflammation. 2021 Sep 15;18(1):201. doi: 10.1186/s12974-021-02266-0.
7
Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies.视神经脊髓炎谱系疾病:从病理生理学到治疗策略。
J Neuroinflammation. 2021 Sep 16;18(1):208. doi: 10.1186/s12974-021-02249-1.
8
Differentiated pattern of complement system activation between MOG-IgG-associated disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder.MOG-IgG 相关疾病与 AQP4-IgG 阳性视神经脊髓炎谱系障碍中补体系统激活的分化模式。
Front Immunol. 2024 Mar 21;15:1320094. doi: 10.3389/fimmu.2024.1320094. eCollection 2024.
9
Variable sensitivity to complement-dependent cytotoxicity in murine models of neuromyelitis optica.视神经脊髓炎小鼠模型中对补体依赖性细胞毒性的可变敏感性
J Neuroinflammation. 2016 Dec 1;13(1):301. doi: 10.1186/s12974-016-0767-4.
10
C3 and C4 complement levels in AQP4-IgG-positive NMOSD and in MOGAD.AQP4-IgG 阳性 NMOSD 和 MOGAD 患者的 C3 和 C4 补体水平。
J Neuroimmunol. 2021 Nov 15;360:577699. doi: 10.1016/j.jneuroim.2021.577699. Epub 2021 Aug 24.

引用本文的文献

1
Low Frequency Ultrasound With Injection of NMO-IgG and Complement Produces Lesions Different From Experimental Autoimmune Encephalomyelitis Mice.低频超声联合注射 NMO-IgG 和补体导致的损伤不同于实验性自身免疫性脑脊髓炎小鼠。
Front Immunol. 2021 Oct 14;12:727750. doi: 10.3389/fimmu.2021.727750. eCollection 2021.
2
Regulatory T cells protect against brain damage by alleviating inflammatory response in neuromyelitis optica spectrum disorder.调节性 T 细胞通过减轻视神经脊髓炎谱系疾病中的炎症反应来保护大脑免受损伤。
J Neuroinflammation. 2021 Sep 15;18(1):201. doi: 10.1186/s12974-021-02266-0.
3
Tanshinone IIA alleviates brain damage in a mouse model of neuromyelitis optica spectrum disorder by inducing neutrophil apoptosis.

本文引用的文献

1
Hydroxychloroquine fails to attenuate lesion development in a mouse model of neuromyelitis optica.羟氯喹未能减轻视神经脊髓炎小鼠模型中的病灶发展。
CNS Neurosci Ther. 2018 Sep;24(9):842-845. doi: 10.1111/cns.12975. Epub 2018 May 14.
2
Designing Human Antibodies by Phage Display.通过噬菌体展示技术设计人源抗体。
Transfus Med Hemother. 2017 Sep;44(5):312-318. doi: 10.1159/000479633. Epub 2017 Aug 25.
3
Low expression of complement inhibitory protein CD59 contributes to humoral autoimmunity against astrocytes.补体抑制蛋白 CD59 的低表达导致针对星形胶质细胞的体液自身免疫。
丹参酮IIA通过诱导中性粒细胞凋亡减轻视神经脊髓炎谱系障碍小鼠模型中的脑损伤。
J Neuroinflammation. 2020 Jun 25;17(1):198. doi: 10.1186/s12974-020-01874-6.
Brain Behav Immun. 2017 Oct;65:173-182. doi: 10.1016/j.bbi.2017.04.023. Epub 2017 May 2.
4
CFHR1-Modified Neural Stem Cells Ameliorated Brain Injury in a Mouse Model of Neuromyelitis Optica Spectrum Disorders.CFHR1修饰的神经干细胞改善了视神经脊髓炎谱系障碍小鼠模型中的脑损伤。
J Immunol. 2016 Nov 1;197(9):3471-3480. doi: 10.4049/jimmunol.1600135. Epub 2016 Sep 26.
5
Eculizumab epitope on complement C5: Progress towards a better understanding of the mechanism of action.依库珠单抗在补体C5上的表位:在更好地理解作用机制方面取得的进展。
Mol Immunol. 2016 Sep;77:126-31. doi: 10.1016/j.molimm.2016.07.016. Epub 2016 Aug 5.
6
Structural basis for therapeutic inhibition of complement C5.补体C5治疗性抑制的结构基础
Nat Struct Mol Biol. 2016 May;23(5):378-86. doi: 10.1038/nsmb.3196. Epub 2016 Mar 28.
7
Treatment of neuromyelitis optica: state-of-the-art and emerging therapies.视神经脊髓炎的治疗:现状与新兴疗法。
Nat Rev Neurol. 2014 Sep;10(9):493-506. doi: 10.1038/nrneurol.2014.141. Epub 2014 Aug 12.
8
Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica: a pilot study.抗白细胞介素-6 受体抗体托珠单抗治疗视神经脊髓炎的疗效:一项初步研究。
Neurology. 2014 Apr 15;82(15):1302-6. doi: 10.1212/WNL.0000000000000317. Epub 2014 Mar 14.
9
C1q-targeted monoclonal antibody prevents complement-dependent cytotoxicity and neuropathology in in vitro and mouse models of neuromyelitis optica.C1q 靶向单克隆抗体可预防视神经脊髓炎的体外和小鼠模型中的补体依赖性细胞毒性和神经病理学。
Acta Neuropathol. 2013 Jun;125(6):829-40. doi: 10.1007/s00401-013-1128-3. Epub 2013 May 16.
10
Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study.依库珠单抗治疗水通道蛋白 4 免疫球蛋白 G 阳性复发性视神经脊髓炎谱系疾病:一项开放标签的初步研究。
Lancet Neurol. 2013 Jun;12(6):554-62. doi: 10.1016/S1474-4422(13)70076-0. Epub 2013 Apr 26.